# Advances against cancer presented at the European oncology congress

> On 26 October 2026, several therapeutic advances against cancer were announced: an immunotherapy extending survival in small‑cell lung cancer, a new class of drugs for gynaecological cancers, and a personalised melanoma vaccine showing promising results. On 29 October, Professor Jean‑Jacques Kiladjian highlighted the gap between these announcements of promising treatments and their actual access for patients. On 30 October, these advances, including the melanoma vaccine, were presented at a European oncology summit.

**In brief**: Ongoing story bringing together 5 events nationwide, followed from 26 October 2026 to 30 October 2026. 17 articles from 12 sources (health); last updated on 30 October 2026 at 12:00.

- Status: ongoing
- Category: Health
- Place: Nationwide
- First detected: 26 October 2026 at 11:15
- Updated: 30 October 2026 at 12:00
- Web page: https://acturadar.com/en/stories/172-advances-against-cancer-presented-at-the-european-oncology-congress

## Timeline (5 events)

### 26 October 2026 — [New immunotherapy extends survival in lung cancer](https://acturadar.com/en/events/717-new-immunotherapy-extends-survival-in-lung-cancer.md)

Two new treatments for small cell lung cancer improve patients' survival, with a survival gain described as "never seen".

2 sources, 4 articles · Nationwide

### 26 October 2026 — [A new family of drugs against gynecological cancers](https://acturadar.com/en/events/842-a-new-family-of-drugs-against-gynecological-cancers.md)

A new family of treatments raises hope in the management of gynecological cancers.

1 sources, 1 articles · Nationwide

### 26 October 2026 — [A promising tailor-made vaccine against melanoma recurrences](https://acturadar.com/en/events/1370-a-promising-tailor-made-vaccine-against-melanoma-recurrences.md)

A personalized vaccine against melanoma shows promising results, with 82% of treated patients not experiencing a recurrence.

9 sources, 10 articles · Nationwide

### 29 October 2026 — [Cancer research: between treatment promises and delays in access to care](https://acturadar.com/en/events/3625-cancer-research-between-treatment-promises-and-delays-in-access-to-care.md)

Following the European oncology congress, Professor Jean-Jacques Kiladjian explains the gap between announcements of promising treatments and their effective access for patients.

1 sources, 1 articles · Nationwide

### 30 October 2026 — [Therapeutic advances against cancer presented at European oncology summit](https://acturadar.com/en/events/4639-therapeutic-advances-against-cancer-presented-at-european-oncology-summit.md)

A melanoma vaccine and promising new treatments are among the medical advances presented at a European oncology summit.

1 sources, 1 articles · Nationwide

---

Cite as: Acturadar, “Advances against cancer presented at the European oncology congress”, https://acturadar.com/en/stories/172-advances-against-cancer-presented-at-the-european-oncology-congress
Methodology: https://acturadar.com/en/methodology